Halozyme Therapeutics Inc (HALO)

53.76 +2.57 (+5.02%) USD  |  NASDAQ  |  Jan 08, 16:00
53.71 -0.05 (-0.09%) After-Hours: 20:00
More

Halozyme Therapeutics Cash and Short Term Investments (Annual): 336.00M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Amicus Therapeutics Inc 286.20M
Lexicon Pharmaceuticals Inc 170.03M
Novavax Inc 568.50M
Kura Oncology Inc 423.96M
TransMedics Group Inc 394.81M